These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Upon closer inspection. As the U.S. imports more drugs and devices, the FDA's overseas initiatives aim to head off trouble at the source. Rhea S Mod Healthc; 2009 Mar; 39(13):28-30. PubMed ID: 19405431 [No Abstract] [Full Text] [Related]
48. Role of packaging in ethylene oxide sterilization. Panella JA Bull Parenter Drug Assoc; 1974; 28(4):188-96. PubMed ID: 4212326 [No Abstract] [Full Text] [Related]
49. New York State and drug lists: a history of confusion. Stetler CJ Med Mark Media; 1978 Sep; 13(9):36, 38, 40 passim. PubMed ID: 10316687 [No Abstract] [Full Text] [Related]
50. Pharma's year of trouble and strife. Frantz S Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339 [No Abstract] [Full Text] [Related]
51. Drug product quality. Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595 [No Abstract] [Full Text] [Related]
52. FDA-USP drug product problem reporting program--an update. Wheatley LS Hosp Formul; 1979 Mar; 14(3):359-60, 365. PubMed ID: 10316797 [No Abstract] [Full Text] [Related]
53. Current good manufacturing practice: proposed revision of certain requirements for finished pharmaceuticals; proposed rule, May 3, 1996 (61 FR 20103), [Docket No. 95N-0362]. Parenteral Drug Association. PDA J Pharm Sci Technol; 1996; 50(6):346-51. PubMed ID: 9038078 [No Abstract] [Full Text] [Related]
54. Reporting drug product defects--JCAHO. Hoffmann RP Hosp Pharm; 1989 Feb; 24(2):143-4. PubMed ID: 10318199 [No Abstract] [Full Text] [Related]
56. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913 [TBL] [Abstract][Full Text] [Related]
58. PDA response. "Guideline for submitting documentation for sterilization process validation in applications for human and veterinary drug products". Parenteral Drug Association. PDA J Pharm Sci Technol; 1995; 49(2):62-6. PubMed ID: 7780746 [No Abstract] [Full Text] [Related]
59. Strategy for surveillance of adverse drug events. Bright RA Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403 [No Abstract] [Full Text] [Related]
60. A review of current technology in parenteral manufacturing. Akers JE; Agalloco JP; Carleton FJ; Korczynski MS J Parenter Sci Technol; 1988; 42(2):53-6. PubMed ID: 3385542 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]